SELECT Trial
Study / Research
A significant study, sponsored by Nova Nordisk, that showed a 20% reduction in severe cardiovascular events in overweight individuals (without Type 2 diabetes) on Semaglutide, independent of weight loss.
Mentioned in 2 videos
Videos Mentioning SELECT Trial

Dr. Bill Harris on the Omega-3 Index: Increasing Omega-3 to Promote Longevity & Transform Health
FoundMyFitness
A 2013 trial that examined prostate cancer incidence in men given alpha-tocopherol or selenium; a controversial sub-analysis claimed a correlation between omega-3 levels and increased prostate cancer risk, but the study design was confounded and results were not confirmed.

The Ozempic Expert: Ozempic Transforms Your Gut Microbiome! People Are Being Overdosed On Ozempic!
The Diary Of A CEO
A significant study, sponsored by Nova Nordisk, that showed a 20% reduction in severe cardiovascular events in overweight individuals (without Type 2 diabetes) on Semaglutide, independent of weight loss.